NASDAQ · THC
Healthcare · Medical - Care Facilities
$273.25
Up+$2.68 (+0.99%)
Updated Nov 1, 2026, 7:11 PM
SID Score
7.5/10
Composite research score
Smart Money
58/100
Neutral
Price performance · THC
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
THC closed at $273.25 after 20 trading sessions, up 5.31% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $266.51 | $274.09 | $265.58 | $273.25 | 1.21M |
| Oct 29, 2026 | $259.01 | $270.97 | $255.50 | $270.57 | 1.46M |
| Oct 28, 2026 | $261.00 | $271.61 | $261.00 | $268.50 | 1.09M |
| Oct 27, 2026 | $271.28 | $275.38 | $256.00 | $262.05 | 1.22M |
| Oct 26, 2026 | $268.93 | $274.98 | $267.33 | $268.95 | 645.68K |
| Oct 23, 2026 | $268.69 | $272.54 | $266.53 | $268.45 | 460K |
| Oct 22, 2026 | $269.62 | $272.88 | $264.61 | $270.63 | 590.19K |
| Oct 21, 2026 | $271.13 | $274.275 | $266.47 | $269.13 | 461.88K |
| Oct 20, 2026 | $267.99 | $272.8096 | $267.76 | $272.32 | 462.06K |
| Oct 19, 2026 | $265.92 | $270.08 | $264.15 | $266.39 | 499.65K |
| Oct 16, 2026 | $276.96 | $278.39 | $265.65 | $267.25 | 827.87K |
| Oct 15, 2026 | $274.83 | $277.60 | $273.76 | $275.13 | 676.88K |
| Oct 14, 2026 | $267.93 | $274.10 | $267.71 | $271.60 | 717.35K |
| Oct 13, 2026 | $268.64 | $269.30 | $265.45 | $266.91 | 600K |
| Oct 12, 2026 | $264.32 | $270.07 | $264.32 | $268.76 | 510K |
| Oct 9, 2026 | $259.83 | $265.975 | $259.83 | $263.78 | 525.58K |
| Oct 8, 2026 | $257.27 | $262.69 | $257.27 | $260.57 | 440.1K |
| Oct 7, 2026 | $256.45 | $261.575 | $256.45 | $259.83 | 475.69K |
| Oct 6, 2026 | $260.72 | $263.46 | $257.06 | $258.47 | 426.77K |
| Oct 5, 2026 | $259.00 | $264.45 | $258.75 | $259.47 | 693.03K |
The latest Smart Investors Daily articles mentioning THC.
Company
Market Activity
Research & News
THC research
Company profile and research snapshot.
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (47 as of December 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 30, 2026 | Guggenheim | Buy | — |
| Oct 16, 2026 | Guggenheim | Buy | — |
| Sep 23, 2026 | BMO Capital | Market Perform | — |
| Sep 18, 2026 | Leerink Partners | Outperform | — |
| Aug 3, 2026 | Wells Fargo | Overweight | — |
No generated briefing is available yet.
Yahoo · Oct 31, 2026
Tenet Healthcare (NYSE:THC) reported third-quarter 2026 net operating revenue of $5.6 billion and consolidated adjusted EBITDA of $1.355 billion, while adjusted diluted earnings per share rose 80% from a year earlier to $6.64. Chairman and Chief Executive Officer Saum Sutaria said the company’s cor
Yahoo · Oct 30, 2026
The health system's push into high-acuity procedures like joint replacements and spinal fusions helped offset declining surgical volumes and payer mix pressures tied to the ACA exchanges.
Yahoo · Oct 30, 2026
Tenet Healthcare raises its 2026 outlook as Q3 earnings surge, hospital margins improve and higher-acuity care drives ambulatory growth despite payer pressures.
Benzinga · Oct 30, 2026
Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and lowers the price target from $307 to $306.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning THC.
